Global Health Industry Innovation Center

What Global Health Industry Innovation Center does

Global Health Industry Innovation Center (GHIC) is a Beijing-based, for-profit medical device innovation incubation platform established in 2018 by Beijing Tsinghua Industrial Development Research Institute (清华工研院). GHIC operates as a multi-service, full-lifecycle platform for early-to-mid stage projects in medical devices, diagnostics, and healthcare services, providing basic services (workspace, business registration, HR, finance/tax, legal, IP), professional services (medical device lifecycle management, quality system support, CE/ISO13485 audit guidance, registration and clinical trial support, market network establishment), and investment/financing matchmaking against a network of 100+ investment institutions led by 荷塘创投 (Hetang Venture Capital) and 水木创投 (Shuimu Venture Capital). The platform is physically located in Building A, Zhongguancun Dongsheng International Science Park, Haidian District, Beijing, and the operating legal entity is 荷塘探索国际健康科技发展（北京）有限公司 (Hetang Explore International Health Technology Development (Beijing) Co., Ltd.).

The platform does not develop proprietary technology products itself; rather, it sources, curates, and accelerates external innovations through a structured ecosystem spanning an advisory team of clinical and investment professionals, an industry-event flywheel (annual Global Health Industry Innovation Conference, the "跨界医聊" dialogue series), and branded training programs (探索计划/Tansuo Plan, 领航计划/Linghang Plan, 启新计划/Qixin Plan). Revenue mechanics are not publicly disclosed but plausibly combine workspace leasing, incubation service fees, training/event sponsorships, and equity participation in incubated portfolio companies. Approximately 22 portfolio companies are showcased across ophthalmology, cardiovascular, oncology, rehabilitation robotics, diagnostic imaging, and biotechnology (examples include 图湃医疗, 超目科技, 富伯医疗, 华卫恒源, 未磁科技, 悟通感控, 曦健科技, 普博医疗, 圣博玛, 海杰亚医疗).

The platform's strategic positioning rests on formal recognition as a Beijing Municipal Science and Technology Enterprise Incubator (4th batch, 2024) and as one of the first batch of Beijing concept verification platforms, alongside institutional partnerships with Peking University First Hospital, the Beijing Medical Robot Industry Innovation Center (IMC), the Beijing Health Commission, and multinationals Boston Scientific and Terumo. It hosted the founding of the Medical-Engineering Integration Working Committee of the Chinese Association for Health Science and Technology Promotion in October 2025, increasingly functioning as a node in China's medical-engineering integration policy apparatus.

Name

Global Health Industry Innovation Center

Legal name

荷塘探索国际健康科技发展（北京）有限公司

Website

https://ghic.cn

Company type

Private

Founded year

2018

Operating status

Operating

Headcount range

51–100 employees

Short description

GHIC is a Beijing-based medical device innovation incubator founded in 2018 by Beijing Tsinghua Industrial Development Research Institute, providing full-lifecycle incubation services to early-to-mid stage medical device, diagnostic, and healthcare innovation companies.

Ownership category

akta.pro rank

Product category

Medical Device Incubation Services

NAICS

Scientific Research and Development Services (5417), Professional, Scientific, and Technical Services (541)

SIC

Services-Commercial Physical & Biological Research (8731), Services-Health Services (8000)

akta.pro primary industry

Quality Assurance, GxP Compliance & Auditing FSP (HLAGAOAE)

akta.pro secondary industries

Clinical Trial Supply, Logistics & Vendor Management FSP (HLAGAOAH), Training & Competency Programs for GxP Compliance (HLAGAKAM)

Keywords

• Medical device incubation
• Healthcare innovation platform
• Medical technology transfer
• Venture capital matching
• Clinical research services

Headquarters

HQ city

Haidian

HQ country

China

HQ region

Asia

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Distribution channels1 record

Marketing channels5 records

Core offering

Global Health Industry Innovation Center (GHIC) is a medical device and healthcare innovation incubation platform initiated by Beijing Tsinghua Industrial Research Institute (北京清华工业开发研究院). It delivers full-life cycle management services to early-to-mid stage medical innovation projects spanning medical devices, diagnostics, and healthcare services. Its offering bundles basic administrative support (space, registration, HR, legal, IP, finance/tax), professional medical-device services (lifecycle management, quality system setup, clinical trials, registration, market networks), and investment/financing matching to 100+ investment institutions, complemented by structured incubation programs such as Tansuo, Linghang, and Qixin Plans.

Product overview

Global Health Industry Innovation Center (GHIC) is a platform-based innovation center initiated and established by the Beijing Tsinghua Industrial Research and Development Institute. Rather than offering a single unified product, GHIC operates as a multi-service platform providing comprehensive support for early and mid-stage medical innovation projects. Its core offerings include: (1) Basic Services encompassing space support, project registration, business setup, HR, accounting, legal, and IP services; (2) Professional Services covering the full medical device product lifecycle — from technical consulting and quality management systems to registration, clinical trials, and market network establishment; (3) Investment and Financing Services connecting innovators with 100+ investment institutions; (4) Platform Ecosystem Services with industrial teams, advisory resources, and global resource networks; and (5) Structured brand programs (Tansuo Plan, Linghang Plan, Qixin Plan) and training/dialogue programs (Kuajia Yiliao Talk, Exploration Plan, Navigation Plan) that bridge clinical needs with engineering and capital. GHIC incubates and showcases approximately 22 portfolio companies across ophthalmology, cardiovascular, oncology, rehabilitation robotics, diagnostic imaging, and biotechnology sectors.

Differentiator

Problem solved

Functional benefit

Products and services

• Basic Services (基础服务) Foundational support services for innovative enterprises incubated on the platform, including space support, project application and certification, business/工商 registration, human resources, accounting and tax services, legal services, and trademark and intellectual property services.
• Professional Services (专业服务) Full-lifecycle management services for medical device enterprises, including technical consulting and R&D support, third-party testing lab resources, medical device registration and inspection, clinical trial support, quality management system setup, CE certification, ISO13485 audit guidance, and market network establishment.
• Investment and Financing Services (投融资服务) Financial support and capital introduction services connecting innovative enterprises with 100+ investment institutions for early-to-mid-stage medical device and healthcare projects.
• Tansuo Plan (探索计划) — Capital Medical Innovation Scholars Program Branded innovation talent cultivation program co-organized with Beijing Health Commission and Tsinghua University, targeting clinical doctors, researchers, and industry professionals to translate clinical needs into commercialized medical innovations.
• Linghang Plan (领航计划) — Healthcare Industry Navigator Program Structured healthcare industry innovation training program developed in collaboration with partners such as Boston Scientific, targeting clinical and industry leaders for innovation capability building.
• Qixin Plan (启新计划) — New Initiative Program for Cardiovascular Innovation Cardiovascular-focused innovation program developed with partners including Terumo (泰尔茂医疗), cultivating next-generation cardiovascular innovation leaders and projects.

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Eight partnerships are on record, tiered core and minor.

• Beijing Tsinghua Industrial Research Institute (北京清华工业开发研究院)coreStrategic or Co-development PartnerTsinghua Industrial Research Institute is the parent organization that initiated and established GHIC. It provides the foundational institutional backing, connecting GHIC to Tsinghua University's research resources and serving as the core strategic anchor of the platform's innovation ecosystem.
• Peking University First Hospital (北京大学第一医院)coreStrategic or Co-development PartnerGHIC and Peking University First Hospital's Clinical Research Achievement Translation Center signed a strategic cooperation agreement on October 24. The partnership aims to promote clinical innovation achievement transformation, leveraging GHIC's resources in policy research, technology innovation, achievement translation, and talent cultivation.
• Beijing Jinguang Shengtai Medical Robot Technology Innovation Center (北京水木东方高端医疗机器人技术创新中心)coreStrategic or Co-development PartnerAlso known as 北京市医疗机器人产业创新中心 (IMC), this partner is a key ecosystem collaborator that co-funded 悟通感控 alongside GHIC. It is a government-guided medical robot industry innovation platform offering CDMO services for high-end medical equipment.
• Chinese Medical Association Biomedical Engineering Society (中国人体健康科技促进会医工融合工作委员会)coreStrategic or Co-development PartnerEstablished in October 2025, this committee aims to build a multi-disciplinary collaboration platform covering medicine, engineering, materials, and information science. GHIC participates in organizing academic exchanges and promoting industry standards for medical-engineering integration.
• Zhongguancun Dongsheng International Science Park (中关村东升国际科学园)minorOthersGHIC is physically located in Zhongguancun Dongsheng International Science Park, leveraging the park's infrastructure and innovation ecosystem resources for its operations.
• Beijing Health Commission (北京市卫生健康委员会)coreStrategic or Co-development PartnerGHIC co-organizes the 首都医疗卫生领域创新力培养—探索计划 with Beijing Health Commission and Tsinghua University, targeting clinical talent cultivation and medical innovation transformation in Beijing.
• Boston ScientificminorStrategic or Co-development PartnerBoston Scientific has collaborated with GHIC on the 领航创新发展计划, serving as a strategic partner for healthcare industry innovation training programs.
• Terumo (泰尔茂)minorStrategic or Co-development PartnerTerumo (泰尔茂医疗) has visited GHIC and expressed interest in medical innovation collaboration, particularly in supporting the 启新计划 cardiovascular initiative.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Regional players

• BioBAY (Suzhou Biomedical Industrial Park): China's leading biomedical industrial park in Suzhou, providing incubation, GMP space, and accelerator programs for hundreds of medtech and biopharma startups. Comparable business model (industrial-park-as-incubator) though operating from Suzhou rather than Beijing.
• Zhangjiang Group (Shanghai Zhangjiang Hi-Tech Park Development): State-backed developer of Shanghai's Zhangjiang Hi-Tech Park, a flagship biomedical and medtech cluster with in-house incubation services. Comparable as a regional medtech innovation hub but anchored in Shanghai.
• Zhongguancun Life Science Park: Beijing's primary biomedical industry cluster providing lab space, shared services, and policy support to medtech and biopharma companies. Comparable as a co-located, government-backed platform targeting early-to-mid-stage medical innovators in the same Haidian/Beijing catchment as GHIC.

Broad incumbents

• WuXi AppTec: China's largest CRO/CDMO with extensive capabilities in medical device testing, regulatory affairs, and clinical trial services. Overlaps with GHIC's professional-services offering for medical-device companies but at vastly larger scale and across the entire drug and device value chain.
• Tigermed (Hangzhou Tigermed Consulting): Leading Chinese clinical CRO providing clinical trial operations, regulatory, and biostatistics services. Overlaps with GHIC's clinical-trial support and regulatory offerings but targets larger biopharma sponsors rather than early-stage medtech startups.
• AstraZeneca iCampus (Wuxi): Global pharmaceutical major AstraZeneca's China innovation campus in Wuxi, funding and partnering with Chinese digital health and medtech startups. Comparable as a multinational-backed health-innovation hub operating inside China and targeting early-stage Chinese medical innovation.
• Roche Innovation Center Shanghai: Roche's China R&D and innovation arm focused on diagnostics and digital health collaborations with Chinese startups and hospitals. Comparable as a multinational pharma R&D and partnership platform operating in China with a similar incubation-collaboration flavor.

Emerging players

• Boehringer Ingelheim China Innovation Hub: Boehringer Ingelheim's Shanghai-based external innovation hub running partnerships and accelerator programs with Chinese healthcare startups. Comparable as a multinational pharma's in-China startup-engagement vehicle with shared portfolio-collaboration logic.

Direct peers

• TusStar (清华科技园孵化器): Tsinghua University's flagship technology business incubator with a wide portfolio of life-sciences and medtech ventures. Most directly comparable to GHIC given shared Tsinghua DNA and similar incubation + venture model, though TusStar's scope is broader than GHIC's medical-device focus.
• Beijing Medical Robot Industry Innovation Center (IMC): Beijing-government-backed medical robot innovation platform that co-invests with GHIC in early-stage medtech (e.g., Wutong Gankong) and offers CDMO services for high-end medical equipment. Operates in the same Beijing ecosystem with overlapping portfolio and advisory functions.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments5 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Global Health Industry Innovation Center